SCI1 Interacts with PRO11 in the STRIPAK Complex of Sordaria

Total Page:16

File Type:pdf, Size:1020Kb

SCI1 Interacts with PRO11 in the STRIPAK Complex of Sordaria Functional analysis of STRIPAK complex components in the filamentous ascomycete Sordaria macrospora Dissertation for the award of the degree “Doctor rerum naturalium” of the Georg-August-Universität Göttingen within the doctoral program Microbiology and Biochemistry of the Georg-August University School of Science (GAUSS) submitted by Eva Johanna Reschka from Tarnowitz (Poland) Göttingen, 2017 Members of the Thesis Committee Prof. Stefanie Pöggeler Department of Genetics of Eukaryotic Microorganisms, Institute of Microbiology and Genetics Prof. Gerhard Braus Department of Molecular Microbiology and Genetics, Institute of Microbiology and Genetics Prof. Henning Urlaub Bioanalytical Mass Spectrometry Group, Max Planck Institute for Biophysical Chemistry Members of the Examination Board 1st Referee Prof. Stefanie Pöggeler Department of Genetics of Eukaryotic Microorganisms, Institute of Microbiology and Genetics 2nd Referee Prof. Kai Heimel Department of Molecular Microbiology and Genetics, Institute of Microbiology and Genetics Further members of the Examination Board Prof. Gerhard Braus Department of Molecular Microbiology and Genetics, Institute of Microbiology and Genetics Prof. Henning Urlaub Bioanalytical Mass Spectrometry Group, Max Planck Institute for Biophysical Chemistry Prof. Rolf Daniel Department of Genomic and Applied Microbiology, Institute of Microbiology and Genetics Prof. Heike Krebber Department of Molecular Genetics, Institute of Microbiology and Genetics Date of oral examination: 18.10.2017 Affirmation I hereby declare that this thesis was written independently and with no other sources and aids than quoted. Göttingen, 25.08.2017 Eva Johanna Reschka This doctoral study was performed in the group of Prof. Stefanie Pöggeler in the Department of Genetics of Eukaryotic Microorganisms at the Institute of Microbiology and Genetics, Georg- August University Göttingen. Table of Contents I. Table of Contents I. Table of Contents ......................................................................................................... i II. List of figures ........................................................................................................... viii III. List of tables ............................................................................................................... x IV. List of figures in the Supplement ................................................................................ xi V. List of videos in the Supplement/DVD ....................................................................... xii VI. List of Abbreviations ................................................................................................ xiii Summary ......................................................................................................................... 1 Zusammenfassung .......................................................................................................... 2 1. Introduction ............................................................................................................... 4 1.1 Components of mammalian STRIPAK complex ............................................................ 6 1.1.1 Striatins .................................................................................................................... 6 1.1.2 PP2A ......................................................................................................................... 8 1.1.3 STRIP1/2 ................................................................................................................... 9 1.1.4 SLMAP/TRAF3IPS ................................................................................................... 10 1.1.5 CTTNBP2/CTTNBP2NL ............................................................................................ 11 1.1.6 MOB3 (phocein) ..................................................................................................... 12 1.1.7 Germinal center kinases and CCM3....................................................................... 13 1.1.7.1 MST3 ........................................................................................................ 14 1.1.7.2 MST4 and STK25 ...................................................................................... 14 1.1.7.3 MINK ........................................................................................................ 14 1.1.8 SIKE/FGFR1OP2 ...................................................................................................... 15 i Table of Contents 1.1.8.1 SIKE ........................................................................................................... 15 1.1.8.2 FGFR1OP2 ................................................................................................ 15 1.2 STRIPAK-like complexes in yeasts and in Drosophila melanogaster ........................... 16 1.2.1 The SIP-SIN-MOR crosstalk in S. pombe ................................................................. 16 1.2.2 The Far complex in Saccharomyces cerevisiae ...................................................... 18 1.2.2.1 The Far complex in S. cerevisiae is involved in pheromone-mediated cell cycle arrest ............................................................................................... 18 1.2.2.2 The Far complex regulates cell growth, autophagy and actin polarization .................................................................................................................. 20 1.2.2.3 MEN regulates mitotic exit and cytokinesis in S. cerevisiae .................... 21 1.2.3 STRIPAK complex in Drosophila melanogaster ...................................................... 22 1.2.3.1 Hippo signaling in D. melanogaster ......................................................... 22 1.2.3.2 Cka in the Jun-N-terminal kinase pathway in D. melanogaster .............. 24 1.2.3.3 The dSTRIPAK activates the Ras-Raf-MAPK/ERK pathway ...................... 25 1.3 Sordaria macrospora is a model organism to study fruiting-body development ......... 26 1.3.1 The STRIPAK complex in S. macrospora regulates sexual development and hyphal fusion .......................................................................................................... 27 1.3.2 Striatin orthologs in filamentous fungi control hyphal fusion, sexual development and vegetative growth ..................................................................... 28 1.3.3 Fungal MOB3 proteins are involved in hyphal fusion, development and vesicular traffic ...................................................................................................................... 29 1.3.4 The fungal STRIP1/2 ortholog and the catalytic PP2ac1 subunit link the fungal STRIPAK to septation and the CWI pathway .......................................................... 30 1.3.5 The SLMAP ortholog PRO45 is part of the fungal STRIPAK complex in S. macrospora ............................................................................................................ 31 1.3.6 Fungal STRIPAK-associated proteins SmGPI1 and GCKIII kinases SmKIN3 and SmKIN24 ................................................................................................................. 31 1.4 Aims of this thesis..................................................................................................... 32 2. Materials and Methods ............................................................................................ 34 ii Table of Contents 2.1 Materials .................................................................................................................. 34 2.1.1 Strains .................................................................................................................... 34 2.1.2 Plasmids ................................................................................................................. 38 2.1.3 Primers ................................................................................................................... 41 2.1.4 Chemicals and materials ........................................................................................ 46 2.1.4.1 Chemicals ................................................................................................. 46 2.1.4.2 Materials .................................................................................................. 47 2.1.5 Kits ......................................................................................................................... 47 2.1.6 Enzymes ................................................................................................................. 48 2.1.7 Antibodies .............................................................................................................. 48 2.1.8 Buffers and solutions ............................................................................................. 48 2.1.9 Media ..................................................................................................................... 51 2.2 Methods ................................................................................................................... 52 2.2.1 Cultivation of microorganisms ............................................................................... 52 2.2.2 Preparation of competent microorganisms and transformation procedure ........ 53 2.2.3 Generation of S. macrospora deletion strains ....................................................... 54 2.2.3.1 Generation of S. macrospora single
Recommended publications
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Downloaded from [266]
    Patterns of DNA methylation on the human X chromosome and use in analyzing X-chromosome inactivation by Allison Marie Cotton B.Sc., The University of Guelph, 2005 A THESIS SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY in The Faculty of Graduate Studies (Medical Genetics) THE UNIVERSITY OF BRITISH COLUMBIA (Vancouver) January 2012 © Allison Marie Cotton, 2012 Abstract The process of X-chromosome inactivation achieves dosage compensation between mammalian males and females. In females one X chromosome is transcriptionally silenced through a variety of epigenetic modifications including DNA methylation. Most X-linked genes are subject to X-chromosome inactivation and only expressed from the active X chromosome. On the inactive X chromosome, the CpG island promoters of genes subject to X-chromosome inactivation are methylated in their promoter regions, while genes which escape from X- chromosome inactivation have unmethylated CpG island promoters on both the active and inactive X chromosomes. The first objective of this thesis was to determine if the DNA methylation of CpG island promoters could be used to accurately predict X chromosome inactivation status. The second objective was to use DNA methylation to predict X-chromosome inactivation status in a variety of tissues. A comparison of blood, muscle, kidney and neural tissues revealed tissue-specific X-chromosome inactivation, in which 12% of genes escaped from X-chromosome inactivation in some, but not all, tissues. X-linked DNA methylation analysis of placental tissues predicted four times higher escape from X-chromosome inactivation than in any other tissue. Despite the hypomethylation of repetitive elements on both the X chromosome and the autosomes, no changes were detected in the frequency or intensity of placental Cot-1 holes.
    [Show full text]
  • Genome-Wide DNA Methylation Analysis of KRAS Mutant Cell Lines Ben Yi Tew1,5, Joel K
    www.nature.com/scientificreports OPEN Genome-wide DNA methylation analysis of KRAS mutant cell lines Ben Yi Tew1,5, Joel K. Durand2,5, Kirsten L. Bryant2, Tikvah K. Hayes2, Sen Peng3, Nhan L. Tran4, Gerald C. Gooden1, David N. Buckley1, Channing J. Der2, Albert S. Baldwin2 ✉ & Bodour Salhia1 ✉ Oncogenic RAS mutations are associated with DNA methylation changes that alter gene expression to drive cancer. Recent studies suggest that DNA methylation changes may be stochastic in nature, while other groups propose distinct signaling pathways responsible for aberrant methylation. Better understanding of DNA methylation events associated with oncogenic KRAS expression could enhance therapeutic approaches. Here we analyzed the basal CpG methylation of 11 KRAS-mutant and dependent pancreatic cancer cell lines and observed strikingly similar methylation patterns. KRAS knockdown resulted in unique methylation changes with limited overlap between each cell line. In KRAS-mutant Pa16C pancreatic cancer cells, while KRAS knockdown resulted in over 8,000 diferentially methylated (DM) CpGs, treatment with the ERK1/2-selective inhibitor SCH772984 showed less than 40 DM CpGs, suggesting that ERK is not a broadly active driver of KRAS-associated DNA methylation. KRAS G12V overexpression in an isogenic lung model reveals >50,600 DM CpGs compared to non-transformed controls. In lung and pancreatic cells, gene ontology analyses of DM promoters show an enrichment for genes involved in diferentiation and development. Taken all together, KRAS-mediated DNA methylation are stochastic and independent of canonical downstream efector signaling. These epigenetically altered genes associated with KRAS expression could represent potential therapeutic targets in KRAS-driven cancer. Activating KRAS mutations can be found in nearly 25 percent of all cancers1.
    [Show full text]
  • Analysis of Protein Complexes Through Model-Based Biclustering of Label-Free Quantitative AP-MS Data
    Molecular Systems Biology 6; Article number 385; doi:10.1038/msb.2010.41 Citation: Molecular Systems Biology 6:385 & 2010 EMBO and Macmillan Publishers Limited All rights reserved 1744-4292/10 www.molecularsystemsbiology.com REPORT Analysis of protein complexes through model-based biclustering of label-free quantitative AP-MS data Hyungwon Choi1, Sinae Kim2, Anne-Claude Gingras3,4 and Alexey I Nesvizhskii1,5,* 1 Department of Pathology, University of Michigan, Ann Arbor, MI, USA, 2 Department of Biostatistics, University of Michigan, Ann Arbor, MI, USA, 3 Samuel Lunenfeld Research Institute at Mount Sinai Hospital, Toronto, Ontario, Canada, 4 Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada and 5 Center for Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA * Corresponding author. Department of Pathology, University of Michigan, 1301 Catherine, 4237 MS1, Ann Arbor, MI 48109, USA. Tel.: þ 1 734 764 3516; Fax: þ 1 734 936 7361; E-mail: [email protected] Received 28.8.09; accepted 7.5.10 Affinity purification followed by mass spectrometry (AP-MS) has become a common approach for identifying protein–protein interactions (PPIs) and complexes. However, data analysis and visualization often rely on generic approaches that do not take advantage of the quantitative nature of AP-MS. We present a novel computational method, nested clustering, for biclustering of label-free quantitative AP-MS data. Our approach forms bait clusters based on the similarity of quantitative interaction profiles and identifies submatrices of prey proteins showing consistent quantitative association within bait clusters. In doing so, nested clustering effectively addresses the problem of overrepresentation of interactions involving baits proteins as compared with proteins only identified as preys.
    [Show full text]
  • Structure-Based Screen Identification of a Mammalian Ste20-Like Kinase 4 (MST4) Inhibitor with Therapeutic Potential for Pituitary Tumors
    Published OnlineFirst December 31, 2015; DOI: 10.1158/1535-7163.MCT-15-0703 Small Molecule Therapeutics Molecular Cancer Therapeutics Structure-Based Screen Identification of a Mammalian Ste20-like Kinase 4 (MST4) Inhibitor with Therapeutic Potential for Pituitary Tumors Weipeng Xiong1,3, Christopher J. Matheson2, Mei Xu1,3, Donald S. Backos2, Taylor S. Mills1, Smita Salian-Mehta1, Katja Kiseljak-Vassiliades1,3, Philip Reigan2, and Margaret E. Wierman1,3 Abstract Pituitary tumors of the gonadotrope lineage are often large described as an Aurora kinase inhibitor, exhibited potent inhi- and invasive, resulting in hypopituitarism. No medical treat- bition of the MST4 kinase at nanomolar concentrations. The ments are currently available. Using a combined genetic and LbT2 gonadotrope pituitary cell hypoxic model was used to test genomic screen of individual human gonadotrope pituitary the ability of this inhibitor to antagonize MST4 actions. Under tumor samples, we recently identified the mammalian ster- short-term severe hypoxia (1% O2), MST4 protection from ile-20 like kinase 4 (MST4) as a protumorigenic effector, driving hypoxia-induced apoptosis was abrogated in the presence of increased pituitary cell proliferation and survival in response to hesperadin. Similarly, under chronic hypoxia (5%), hesperadin a hypoxic microenvironment. To identify novel inhibitors of blocked the proliferative and colony-forming actions of MST4 the MST4 kinase for potential future clinical use, computation- as well as the ability to activate specific downstream signaling al-based virtual library screening was used to dock the Sell- and hypoxia-inducible factor-1 effectors. Together, these data eckChem kinase inhibitor library into the ATP-binding site of identify hesperadin as the first potent, selective inhibitor of the the MST4 crystal structure.
    [Show full text]
  • Functional Annotation of Genes Overlapping Copy Number Variants in Autistic Patients: Focus on Axon Pathfinding
    136 Current Genomics, 2010, 11, 136-145 Functional Annotation of Genes Overlapping Copy Number Variants in Autistic Patients: Focus on Axon Pathfinding Silvia Sbacchi1, Francesco Acquadro2, Ignazio Calò1, Francesco Calì3 and Valentino Romano*,1,3 1Dipartimento di Oncologia Sperimentale e Applicazioni Cliniche, Università degli Studi di Palermo, Palermo; 2Molecular Cytogenetics Group, Centro Nacional de Investigaciones Oncologicas (C.N.I.O.), and Centro de Investiga- ciones de Enfermidades Raras (CIBERER), Madrid, Spain; 3Associazione Oasi Maria SS. (I.R.C.C.S.), Troina (EN), Italy Abstract: We have used Gene Ontology (GO) and pathway analyses to uncover the common functions associated to the genes overlapping Copy Number Variants (CNVs) in autistic patients. Our source of data were four published studies [1- 4]. We first applied a two-step enrichment strategy for autism-specific genes. We fished out from the four mentioned stud- ies a list of 2928 genes overall overlapping 328 CNVs in patients and we first selected a sub-group of 2044 genes after excluding those ones that are also involved in CNVs reported in the Database of Genomic Variants (enrichment step 1). We then selected from the step 1-enriched list a sub-group of 514 genes each of which was found to be deleted or dupli- cated in at least two patients (enrichment step 2). The number of statistically significant processes and pathways identified by the Database for Annotation, Visualization and Integrated Discovery and Ingenuity Pathways Analysis softwares with the step 2-enriched list was significantly higher compared to the step 1-enriched list. In addition, statistically significant GO terms, biofunctions and pathways related to nervous system development and function were exclusively identified by the step 2-enriched list of genes.
    [Show full text]
  • A Semantic Approach for Knowledge Capture of Microrna-Target Gene Interactions
    2015 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) A semantic approach for knowledge capture of microRNA-target gene interactions Jingshan Huang* Fernando Gutierrez Dejing Dou School of Computing, University of South Alabama CIS Dept., University of Oregon CIS Dept., University of Oregon Mobile, Alabama 36688, U.S.A. Eugene, Oregon 97403, U.S.A. Eugene, Oregon 97403, U.S.A. Judith A. Blake Karen Eilbeck Darren A. Natale The Jackson Laboratory School of Medicine, University of Utah Georgetown University Medical Center Bar Harbor, Maine 04609, U.S.A. Salt Lake City, Utah 84112, U.S.A. Washington D.C. 20007, U.S.A. Barry Smith Yu Lin Xiaowei Wang Dept. Philosophy, University at Buffalo University of Miami Washington University School of Medicine Buffalo, New York 14260, U.S.A. Miami, Florida 33146, U.S.A. St. Louis, Missouri 63110, U.S.A. Zixing Liu Ming Tan Alan Ruttenberg MCI, University of South Alabama MCI, University of South Alabama Dental Medicine, University at Buffalo Mobile, Alabama 36604, U.S.A. Mobile, Alabama 36604, U.S.A. Buffalo, New York 14214, U.S.A. Abstract—Research has indicated that microRNAs (miRNAs), Conventionally, data end users (that is, biologists, bioin- a special class of non-coding RNAs (ncRNAs), can perform formaticians, and clinical investigators) need to search for important roles in different biological and pathological processes. (1) biologically validated miRNA targets (for example, by miRNAs’ functions are realized by regulating their respective querying the PubMed database [3]) and (2) computationally target genes (targets). It is thus critical to identify and analyze putative miRNA targets (for example, by initiating inquiries miRNA-target interactions for a better understanding and de- on various prediction databases or websites such as miRDB lineation of miRNAs’ functions.
    [Show full text]
  • STRIPAK Complexes in Cell Signaling and Cancer
    Oncogene (2016), 1–9 © 2016 Macmillan Publishers Limited All rights reserved 0950-9232/16 www.nature.com/onc REVIEW STRIPAK complexes in cell signaling and cancer Z Shi1,2, S Jiao1 and Z Zhou1,3 Striatin-interacting phosphatase and kinase (STRIPAK) complexes are striatin-centered multicomponent supramolecular structures containing both kinases and phosphatases. STRIPAK complexes are evolutionarily conserved and have critical roles in protein (de) phosphorylation. Recent studies indicate that STRIPAK complexes are emerging mediators and regulators of multiple vital signaling pathways including Hippo, MAPK (mitogen-activated protein kinase), nuclear receptor and cytoskeleton remodeling. Different types of STRIPAK complexes are extensively involved in a variety of fundamental biological processes ranging from cell growth, differentiation, proliferation and apoptosis to metabolism, immune regulation and tumorigenesis. Growing evidence correlates dysregulation of STRIPAK complexes with human diseases including cancer. In this review, we summarize the current understanding of the assembly and functions of STRIPAK complexes, with a special focus on cell signaling and cancer. Oncogene advance online publication, 15 February 2016; doi:10.1038/onc.2016.9 INTRODUCTION in the central nervous system and STRN4 is mostly abundant in Recent proteomic studies identified a group of novel multi- the brain and lung, whereas STRN3 is ubiquitously expressed in 5–9 component complexes named striatin (STRN)-interacting phos- almost all tissues. STRNs share a
    [Show full text]
  • Structure-Based Screen Identification of a Mammalian Ste20-Like Kinase 4 (MST4) Inhibitor with Therapeutic Potential for Pituitary Tumors
    Published OnlineFirst December 31, 2015; DOI: 10.1158/1535-7163.MCT-15-0703 Small Molecule Therapeutics Molecular Cancer Therapeutics Structure-Based Screen Identification of a Mammalian Ste20-like Kinase 4 (MST4) Inhibitor with Therapeutic Potential for Pituitary Tumors Weipeng Xiong1,3, Christopher J. Matheson2, Mei Xu1,3, Donald S. Backos2, Taylor S. Mills1, Smita Salian-Mehta1, Katja Kiseljak-Vassiliades1,3, Philip Reigan2, and Margaret E. Wierman1,3 Abstract Pituitary tumors of the gonadotrope lineage are often large described as an Aurora kinase inhibitor, exhibited potent inhi- and invasive, resulting in hypopituitarism. No medical treat- bition of the MST4 kinase at nanomolar concentrations. The ments are currently available. Using a combined genetic and LbT2 gonadotrope pituitary cell hypoxic model was used to test genomic screen of individual human gonadotrope pituitary the ability of this inhibitor to antagonize MST4 actions. Under tumor samples, we recently identified the mammalian ster- short-term severe hypoxia (1% O2), MST4 protection from ile-20 like kinase 4 (MST4) as a protumorigenic effector, driving hypoxia-induced apoptosis was abrogated in the presence of increased pituitary cell proliferation and survival in response to hesperadin. Similarly, under chronic hypoxia (5%), hesperadin a hypoxic microenvironment. To identify novel inhibitors of blocked the proliferative and colony-forming actions of MST4 the MST4 kinase for potential future clinical use, computation- as well as the ability to activate specific downstream signaling al-based virtual library screening was used to dock the Sell- and hypoxia-inducible factor-1 effectors. Together, these data eckChem kinase inhibitor library into the ATP-binding site of identify hesperadin as the first potent, selective inhibitor of the the MST4 crystal structure.
    [Show full text]
  • Transcriptional and Post-Transcriptional Profile of Human Chromosome 21
    Downloaded from genome.cshlp.org on October 6, 2021 - Published by Cold Spring Harbor Laboratory Press Methods Transcriptional and post-transcriptional profile of human chromosome 21 Sergey I. Nikolaev,1,5 Samuel Deutsch,1,5 Raphael Genolet,2 Christelle Borel,1 Leila Parand,1 Catherine Ucla,1 Frederic Schu¨tz,3 Genevieve Duriaux Sail,1 Yann Dupre´,1 Pascale Jaquier-Gubler,2 Tanguy Araud,2 Beatrice Conne,1 Patrick Descombes,4 Jean-Dominique Vassalli,1 Joseph Curran,2 and Stylianos E. Antonarakis1,6 1Department of Genetic Medicine and Development, University of Geneva Medical School, CH-1211 Geneva, Switzerland; 2Department of Microbiology and Molecular Medicine, University of Geneva Medical School, CH-1211 Geneva, Switzerland; 3Swiss Bioinformatics Institute, Genopode Builiding, CH-1015 Lausanne, Switzerland; 4Genomics Platform, University of Geneva Medical School, CH-1211 Geneva, Switzerland Recent studies have demonstrated extensive transcriptional activity across the human genome, a substantial fraction of which is not associated with any functional annotation. However, very little is known regarding the post-transcriptional processes that operate within the different classes of RNA molecules. To characterize the post-transcriptional properties of expressed sequences from human chromosome 21 (HSA21), we separated RNA molecules from three cell lines (GM06990, HeLa S3, and SK-N-AS) according to their ribosome content by sucrose gradient fractionation. Poly- ribosomal-associated RNA and total RNA were subsequently hybridized to genomic tiling arrays. We found that ;50% of the transcriptional signals were located outside of annotated exons and were considered as TARs (transcriptionally active regions). Although TARs were observed among polysome-associated RNAs, RT-PCR and RACE experiments revealed that ;40% were likely to represent nonspecific cross-hybridization artifacts.
    [Show full text]
  • The Genetics of the Mood Disorder Spectrum: Genome-Wide Association Analyses of More Than 185,000 Cases and 439,000 Controls
    Coleman, J. R.I. et al. (2020) The genetics of the mood disorder spectrum: genome-wide association analyses of more than 185,000 cases and 439,000 controls. Biological Psychiatry, 88(2), pp. 169-184. (doi: 10.1016/j.biopsych.2019.10.015) There may be differences between this version and the published version. You are advised to consult the publisher’s version if you wish to cite from it. http://eprints.gla.ac.uk/208027/ Deposited on 11 December 2019 Enlighten – Research publications by members of the University of Glasgow http://eprints.gla.ac.uk 1 Title: The genetics of the mood disorder spectrum: genome-wide association 2 analyses of over 185,000 cases and 439,000 controls 3 Authors: Jonathan R. I. Coleman1;2, Héléna A. Gaspar1;2, Julien Bryois3, Bipolar 4 Disorder Working Group of the Psychiatric Genomics Consortium4, Major Depressive 5 Disorder Working Group of the Psychiatric Genomics Consortium4, Gerome Breen1;2 6 Affiliations: 7 1. Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, 8 Psychology and Neuroscience, King's College London, London, United Kingdom 9 2. NIHR Maudsley Biomedical Research Centre, King's College London, 10 London, United Kingdom 11 3. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 12 Stockholm, Sweden 13 4. Full consortium authorship listed in Article Information 14 15 Correspondence to: Gerome Breen, Social, Genetic and Developmental Psychiatry 16 Centre, Institute of Psychiatry, Psychology and Neuroscience, London, SE5 8AF, 17 UK, [email protected], +442078480409 18 Short title: GWAS of the mood disorder spectrum 19 Keywords: major depressive disorder; bipolar disorder; mood disorders; affective 20 disorders; genome-wide association study; genetic correlation 21 Abstract: 239 words 22 Main text: 3998 words (including citations and headers) 23 Tables: 1 24 Figures: 5 25 Supplementary Materials: 2 (Materials and Figures, Tables) 1 1 2 Abstract 3 Background 4 Mood disorders (including major depressive disorder and bipolar disorder) affect 10- 5 20% of the population.
    [Show full text]
  • MST4 Regulates Epithelial–Mesenchymal Transition of Choriocarcinoma by Mediating TGF- Β1 Expression
    OncoTargets and Therapy Dovepress open access to scientific and medical research Open Access Full Text Article ORIGINAL RESEARCH MST4 Regulates Epithelial–Mesenchymal Transition of Choriocarcinoma by Mediating TGF- β1 Expression This article was published in the following Dove Press journal: OncoTargets and Therapy Hanxi Yu 1,* Background: Mammalian Ste20-like kinase 4 (MST4), also known as serine/threonine Weichen Zhang2,* kinase 26 (STK26), promotes development of several cancers and is found to be highly Peilin Han1 expressed in the placenta. However, in choriocarcinoma that originated from the placenta, the Beng Yang2 expression of MST4 was undetermined and its mechanism was unknown. In this study, the Xiaode Feng 2 expression of MST4 in choriocarcinoma as well as the underlying mechanism was explored. Purpose: To detect the expression of MST4 in patient samples and mechanism of mediating Ping Zhou1 EMT by MST4 in choriocarcinoma. Xiaoxu Zhu1 3 Patients and Methods: The metastatic lesions of choriocarcinoma (n=17) and volunteer Bingqian Zhou villus (n=17) were collected to determine MST4 expression using immunohistochemistry and 4 Wei Chen H&E staining. We use siRNA and lentiviral vector to knockdown MST4 and use plasmid to 1 Jianhua Qian overexpress MST4 in choriocarcinoma. Then, we apply real-time polymerase chain reaction 2 Jun Yu (RT-PCR), Western blot assay and immunofluorescence assay to detect target protein expres­ 1Department of Gynecology, The First sions. Cell invasion and migration and cell proliferation were detected by transwell assay and Affiliated Hospital of Zhejiang University, wound healing assay and CCK-8 and cell colony formation. School of Medicine, Hangzhou 310006, Results: MST4 is lowly expressed in the metastatic lesions of choriocarcinoma patients when People’s Republic of China; 2Division of Hepatobiliary and Pancreatic Surgery, compared with normal villus.
    [Show full text]